Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhonggui He

Showing results (261-270 of 451) with videos related to

Pageof 46
Sort By:
Current Drug Metabolism|October 22, 2019
Monocarboxylate Transporter 1 in Brain Diseases and CancersYixin Sun, Jin Sun, Zhonggui He, et al.
Artificial Cells, Nanomedicine, and Biotechnology|October 5, 2017
L-Carnitine-conjugated nanoparticles to promote permeation across blood-brain barrier and to target glioma cells for drug delivery via the novel organic cation/carnitine transporter OCTN2Longfa Kou, Yanxian Hou, Qing Yao, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 22, 2018
Mitochondria-targeted prostate cancer therapy using a near-infrared fluorescence dye-monoamine oxidase A inhibitor conjugateQingzhi Lv, Xiaoguang Yang, Menglin Wang, et al.
International Journal of Pharmaceutics|June 10, 2009
Development of a chemically stable 10-hydroxycamptothecin nanosuspensionsXiaohui Pu, Jin Sun, Yan Wang, et al.
Asian Journal of Pharmaceutical Sciences|July 9, 2020
Ratiometric delivery of doxorubicin and berberine by liposome enables superior therapeutic index than Doxil<sup>Ⓡ</sup>Ruoshi Zhang, Yingxi Zhang, Yue Zhang, et al.
Asian Journal of Pharmaceutical Sciences|February 28, 2020
Co-amorphous solid dispersion systems of lacidipine-spironolactone with improved dissolution rate and enhanced physical stabilityZhaomeng Wang, Mengchi Sun, Tian Liu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 3, 2019
Tyrosine modified irinotecan-loaded liposomes capable of simultaneously targeting LAT1 and ATB<sup>0,+</sup> for efficient tumor therapyZhenjie Wang, Dongxu Chi, Xingchen Wu, et al.
Colloids and Surfaces. B, Biointerfaces|February 10, 2016
Large amino acid transporter 1 mediated glutamate modified docetaxel-loaded liposomes for glioma targetingLin Li, Xingsheng Di, Shenwu Zhang, et al.
Acta Pharmaceutica Sinica. B|October 22, 2020
Remote loading paclitaxel-doxorubicin prodrug into liposomes for cancer combination therapyJiang Yu, Yingli Wang, Shuang Zhou, et al.
Nano Letters|May 18, 2022
Boarding Oncolytic Viruses onto Tumor-Homing Bacterium-Vessels for Augmented Cancer ImmunotherapyMengchi Sun, Shihua Yang, Hanwei Huang, et al.
Pageof 46

Showing results (261-270 of 451) with videos related to

Sort By:
Pageof 46
Current Drug Metabolism|October 22, 2019
Monocarboxylate Transporter 1 in Brain Diseases and CancersYixin Sun, Jin Sun, Zhonggui He, et al.
Artificial Cells, Nanomedicine, and Biotechnology|October 5, 2017
L-Carnitine-conjugated nanoparticles to promote permeation across blood-brain barrier and to target glioma cells for drug delivery via the novel organic cation/carnitine transporter OCTN2Longfa Kou, Yanxian Hou, Qing Yao, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 22, 2018
Mitochondria-targeted prostate cancer therapy using a near-infrared fluorescence dye-monoamine oxidase A inhibitor conjugateQingzhi Lv, Xiaoguang Yang, Menglin Wang, et al.
International Journal of Pharmaceutics|June 10, 2009
Development of a chemically stable 10-hydroxycamptothecin nanosuspensionsXiaohui Pu, Jin Sun, Yan Wang, et al.
Asian Journal of Pharmaceutical Sciences|July 9, 2020
Ratiometric delivery of doxorubicin and berberine by liposome enables superior therapeutic index than Doxil<sup>Ⓡ</sup>Ruoshi Zhang, Yingxi Zhang, Yue Zhang, et al.
Asian Journal of Pharmaceutical Sciences|February 28, 2020
Co-amorphous solid dispersion systems of lacidipine-spironolactone with improved dissolution rate and enhanced physical stabilityZhaomeng Wang, Mengchi Sun, Tian Liu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 3, 2019
Tyrosine modified irinotecan-loaded liposomes capable of simultaneously targeting LAT1 and ATB<sup>0,+</sup> for efficient tumor therapyZhenjie Wang, Dongxu Chi, Xingchen Wu, et al.
Colloids and Surfaces. B, Biointerfaces|February 10, 2016
Large amino acid transporter 1 mediated glutamate modified docetaxel-loaded liposomes for glioma targetingLin Li, Xingsheng Di, Shenwu Zhang, et al.
Acta Pharmaceutica Sinica. B|October 22, 2020
Remote loading paclitaxel-doxorubicin prodrug into liposomes for cancer combination therapyJiang Yu, Yingli Wang, Shuang Zhou, et al.
Nano Letters|May 18, 2022
Boarding Oncolytic Viruses onto Tumor-Homing Bacterium-Vessels for Augmented Cancer ImmunotherapyMengchi Sun, Shihua Yang, Hanwei Huang, et al.
Pageof 46